MainStay Epoch US Equity Yield R3 (EPLTX)
18.58
-0.05 (-0.27%)
USD |
Jun 29 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.42% | 1.051B | 1.40% | 16.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -4.741M | -0.78% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks current income and capital appreciation. The fund generally invests in a diversified portfolio consisting of equity securities of U.S. companies that have a history of attractive dividend yields and positive growth in operating cash flow. It invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying U.S. companies across all market capitalizations. The fund may invest up to 15% of its net assets in foreign securities. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | EPLCX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | New York Life Investment Management LLC |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Michael Welhoelter | 13.09 yrs |
| William Priest | 13.09 yrs |
| John Tobin | 9.26 yrs |
| Kera Van Valen | 9.26 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
42
-4.741M
-5.417B
Category Low
19.57B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2022
Performance Versus Category
As of June 29, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of June 29, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Chevron Corp | 2.40% | 146.98 | -1.97% |
| AbbVie Inc | 2.21% | 154.14 | 1.08% |
| Merck & Co Inc | 2.18% | 92.51 | 0.67% |
| Broadcom Inc | 2.06% | 490.41 | -1.61% |
| MetLife Inc | 2.01% | 62.93 | -1.27% |
| Emerson Electric Co | 1.96% | 80.51 | -1.24% |
| UnitedHealth Group Inc | 1.95% | 515.71 | 1.43% |
| Johnson & Johnson | 1.91% | 176.99 | 0.03% |
| Medtronic PLC | 1.87% | 90.42 | 1.37% |
| Bank of America Corp | 1.71% | 31.86 | -1.24% |
Basic Info
| Investment Strategy | |
| The investment seeks current income and capital appreciation. The fund generally invests in a diversified portfolio consisting of equity securities of U.S. companies that have a history of attractive dividend yields and positive growth in operating cash flow. It invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying U.S. companies across all market capitalizations. The fund may invest up to 15% of its net assets in foreign securities. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | EPLCX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | New York Life Investment Management LLC |
| Prospectus Benchmark Index | |
| Russell 1000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Michael Welhoelter | 13.09 yrs |
| William Priest | 13.09 yrs |
| John Tobin | 9.26 yrs |
| Kera Van Valen | 9.26 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-29-22) | 1.40% |
| 30-Day SEC Yield (5-31-22) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 17.57 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/8/2017 |
| Last Annual Report Date | 10/31/2021 |
| Last Prospectus Date | 2/28/2022 |
| Share Classes | |
| EPLBX | B |
| EPLCX | Inst |
| EPLDX | Retirement |
| EPLIX | Inv |
| EPLKX | C |
| EPLMX | Other |
| EPLPX | A |
| EPLRX | Retirement |
| EPLSX | Retirement |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |